Chemical Structure : L-006235
CAS No.: 294623-49-7
货号: PC-60641Not For Human Use, Lab Use Only.
L-006235 (L-235, CRA-013783) is a potent, selective, orally bioavailable cathepsin K inhibitor with IC50 of 0.25 nM, displays >4,000-fold selectivity over cathepsins B, L and S.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1280 | In stock | |
10 mg | ¥1980 | In stock | |
25 mg | ¥3280 | In stock | |
50 mg | ¥5280 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
L-006235 (L-235, CRA-013783) is a potent, selective, orally bioavailable cathepsin K inhibitor with IC50 of 0.25 nM, displays >4,000-fold selectivity over cathepsins B, L and S.
L-006235 exhibits an IC50 of 28 nM at cellular level in human osteoclasts, >1,000-fold selectivity against cathepsin S.
L-006235 reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
分子量 | 466.6 | |
分子式 | C24H30N6O2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
100 mM in DMSO |
|
Chemical Name/SMILES |
N-[1-[[(Cyanomethyl)amino]carbonyl]cyclohexyl]-4-[2-(4-methyl-1-piperazinyl)-4-thiazolyl]benzamide |
1. Palmer JT, et al. J Med Chem. 2005 Dec 1;48(24):7520-34.
2. Falgueyret JP, et al. J Med Chem. 2005 Dec 1;48(24):7535-43.
3. Svelander L, et al. Eur J Pharmacol. 2009 Jun 24;613(1-3):155-62.
4. Hayami T, et al. Bone. 2012 Jun;50(6):1250-9.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright